Dmitry Balyasny’s Accendra Health ACH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-542,036
| Closed | -$2.6M | – | 3433 |
|
|
2025
Q3 | $2.6M | Buy |
+542,036
| New | +$3.45M | ﹤0.01% | 1676 |
|
|
2025
Q2 | – | Sell |
-28,167
| Closed | -$254K | – | 3209 |
|
|
2025
Q1 | $254K | Buy |
+28,167
| New | +$297K | ﹤0.01% | 2515 |
|
|
2024
Q4 | – | Sell |
-349,191
| Closed | -$5.48M | – | 3126 |
|
|
2024
Q3 | $5.48M | Buy |
349,191
+290,093
| +491% | +$4.39M | 0.01% | 1217 |
|
|
2024
Q2 | $798K | Buy |
+59,098
| New | +$1.21M | ﹤0.01% | 1876 |
|
|
2023
Q3 | – | Sell |
-30,757
| Closed | -$586K | – | 2589 |
|
|
2023
Q2 | $586K | Sell |
30,757
-163,491
| -84% | -$2.92M | ﹤0.01% | 1800 |
|
|
2023
Q1 | $2.83M | Buy |
194,248
+185,017
| +2,004% | +$3.31M | 0.01% | 1325 |
|
|
2022
Q4 | $180K | Buy |
9,231
+919
| +11% | +$17.9K | ﹤0.01% | 2155 |
|
|
2022
Q3 | $200K | Buy |
+8,312
| New | +$256K | ﹤0.01% | 2314 |
|
|
2022
Q1 | – | Sell |
-144,177
| Closed | -$6.27M | – | 2741 |
|
|
2021
Q4 | $6.27M | Sell |
144,177
-272,991
| -65% | -$10.7M | 0.02% | 779 |
|
|
2021
Q3 | $13.1M | Buy |
+417,168
| New | +$16.4M | 0.05% | 477 |
|
|
2020
Q4 | – | Sell |
-24,152
| Closed | -$606K | – | 1593 |
|
|
2020
Q3 | $606K | Buy |
+24,152
| New | +$352K | ﹤0.01% | 1075 |
|
|
2018
Q4 | – | Sell |
-18,722
| Closed | -$309K | – | 1649 |
|
|
2018
Q3 | $309K | Buy |
+18,722
| New | +$318K | ﹤0.01% | 1498 |
|
|
2018
Q2 | – | Sell |
-16,664
| Closed | -$259K | – | 2049 |
|
|
2018
Q1 | $259K | Buy |
+16,664
| New | +$297K | ﹤0.01% | 1669 |
|
|
2017
Q4 | – | Sell |
-285,950
| Closed | -$8.35M | – | 2234 |
|
|
2017
Q3 | $8.35M | Sell |
285,950
-676,724
| -70% | -$20M | 0.03% | 562 |
|
|
2017
Q2 | $31M | Buy |
962,674
+947,974
| +6,449% | +$31.1M | 0.13% | 215 |
|
|
2017
Q1 | $509K | Sell |
14,700
-128
| -0.9% | -$4.57K | ﹤0.01% | 1292 |
|
|
2016
Q4 | $523K | Buy |
+14,828
| New | +$501K | ﹤0.01% | 1140 |
|
|
2016
Q2 | – | Sell |
-17,970
| Closed | -$726K | – | 1368 |
|
|
2016
Q1 | $726K | Buy |
17,970
+5,910
| +49% | +$220K | ﹤0.01% | 814 |
|
|
2015
Q4 | $434K | Buy |
+12,060
| New | +$436K | ﹤0.01% | 872 |
|
|
2015
Q3 | – | Sell |
-10,450
| Closed | -$355K | – | 1318 |
|
|
2015
Q2 | $355K | Sell |
10,450
-634,561
| -98% | -$21.4M | ﹤0.01% | 929 |
|
|
2015
Q1 | $21.8M | Buy |
645,011
+10,387
| +2% | +$362K | 0.18% | 180 |
|
|
2014
Q4 | $22.3M | Buy |
+634,624
| New | +$21.4M | 0.2% | 142 |
|
Other funds holding ACH
CCM
ICM
PCMI
Dmitry Balyasny's ACH Position: Q4 2025 in Review
Dmitry Balyasny sold out of Accendra Health (ACH) in Q4 2025, closing a stake of 542,036 shares — an estimated $2.6M sold.
Dmitry Balyasny first reported a position in ACH in Q4 2014 and held it in 22 quarters. The position peaked at $31M in Q2 2017. 168 funds tracked by Wall St. Rank hold ACH as of Q4 2025.
- Dmitry Balyasny reported no remaining Accendra Health position as of Q4 2025 after selling out during the quarter.
- Dmitry Balyasny sold 542,036 Accendra Health shares in Q4 2025, an estimated $2.6M.
- Dmitry Balyasny first reported a position in Accendra Health in Q4 2014 and held it in 22 quarters.
- Dmitry Balyasny's Accendra Health position peaked at $31M in Q2 2017.
- 168 funds tracked by Wall St. Rank held Accendra Health as of Q4 2025.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.